Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
Therapeutic Advances in Drug Safety
Published online on June 18, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Background:Belimumab is a biologic agent used in the treatment of systemic lupus erythematosus (SLE). However, its safety profile during pregnancy has not been fully established, and real-world evidence regarding its association with adverse pregnancy ...
Background:Belimumab is a biologic agent used in the treatment of systemic lupus erythematosus (SLE). However, its safety profile during pregnancy has not been fully established, and real-world evidence regarding its association with adverse pregnancy ...